Table 2.
Inpatient, Outpatient, Emergency and Pharmacy Service Utilization, Overall and by Primary Diagnosis
| Any Visits | Mental Health | Non-Mental Health | ||||
|---|---|---|---|---|---|---|
| Inpatient Services | N | % | N | % | N | % |
|
| ||||||
| Children Receiving Inpatient Services - N (%) | 1,564 | 31.4 | 1,455 | 29.3 | 174 | 3.5 |
| Outpatient Services | N | % | N | % | N | % |
|
| ||||||
| Children Receiving Outpatient Services, N (%) | 4,963 | 99.8 | 4,963 | 100.0 | 4,581 | 92.3 |
| Outpatient Visits per Patient and Type of Service | ||||||
| Mean (SD) | 19.6 | 16.3 | 14.1 | 13.9 | 5.4 | 7.3 |
| Median (IQR) | 15.0 | 18.0 | 10.0 | 16.0 | 3.0 | 6.0 |
|
| ||||||
| Emergency Services | N | % | N | % | N | % |
|
| ||||||
| Children Receiving Emergency Room Services, N (%) | 302 | 6.0 | 283 | 5.7 | 266 | 5.3 |
|
| ||||||
| Pharmacy Services a | N | % | N | % | N | % |
|
| ||||||
| Children Receiving Pharmacy Services, N (%) | 4,631 | 93.1 | 4,342 | 87.3 | 3,690 | 74.2 |
a
Pharmacy services for mental health include the following psychotropic medications: lithium, anticonvulsants, antipsychotics, antidepressants, stimulants, anxiolytics/sedatives/hypnotics, and other psychotropic agents (including anti-parkinsonian agents, and two alpha-agonists prescribed for attention deficit hyperactivity disorder - clonidine and guanfacine).